Part II: Cardiac drug and psychotropic drug interactions: Significance and recommendations

General Hospital Psychiatry

Volumn 21, Issue 6, 1999, Pages 408-429

  Strain, James J ^a   Caliendo, Gina ^b   Alexis, Jeffrey D ^a   Lowe III, R Sandlin ^a   Karim, Anwarul ^a   Loigman, Mark ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADRENALIN; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; ALPRENOLOL; AMANTADINE; AMIODARONE; AMPHETAMINE; ATROPINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CARDIOVASCULAR AGENT; CHLORAL HYDRATE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; COLESTIPOL; COLESTYRAMINE; CYTOCHROME P450; CYTOCHROME P450 3A4; DIAZEPAM; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; ENALAPRIL; FLECAINIDE; FLUOXETINE; FLUVOXAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; HALOPERIDOL; HYDRALAZINE; IBUTILIDE; INDOMETACIN; LISINOPRIL; LITHIUM; LOSARTAN; MEPROBAMATE; METOPROLOL; MEVINOLIN; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEOMYCIN; NIMODIPINE; NORADRENALIN; OLANZAPINE; PAROXETINE; PHENOBARBITAL; PHENOTHIAZINE DERIVATIVE; PHENYLEPHRINE; PROPAFENONE; PROPRANOLOL; PSYCHOTROPIC AGENT; QUINIDINE; SALICYLIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIMVASTATIN; THIAZIDE DIURETIC AGENT; THIORIDAZINE; TICLOPIDINE; TRAZODONE; TRIAMTERENE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VERAPAMIL; WARFARIN;

AFFECTIVE NEUROSIS; ALGORITHM; ARTICLE; BLEEDING; CARDIOLOGY; COMPACT DISK; CONFUSION; DATA BASE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG INFORMATION; DRUG INTERACTION; DRUG METABOLISM; ENZYME ACTIVITY; FOOD DRUG INTERACTION; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHYROIDISM; INFORMATION PROCESSING; INFORMATION SERVICE; INOTROPISM; INSOMNIA; INTERNET; IRRITABILITY; MEDICAL INFORMATION; MEDICAL LITERATURE; NAUSEA; PHYSICIAN; PSYCHIATRY; STANDING; TACHYCARDIA; TECHNIQUE; VOMITING; PRACTICE GUIDELINE;

CARDIOVASCULAR AGENTS; DATABASES; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; GUIDELINES; HUMANS; INTERNET; PSYCHOTROPIC DRUGS;

EID: 0033217122     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-8343(00)00049-9     Document Type: Article

References (26)

1. Strain J.J., Caliendo G., Himelein C. Part II Drug-psychotropic drug interactions and end organ dysfunction: Clinical management recommendations, selected bibliography, and updating strategies . Gen Hosp Psychiatry. 18:1996;294-375.
2. Strain J.J., Caliendo G., Himelein C. Using computer databases to predict and avoid drug-drug interactions in the cancer patient requiring psychotropics. Psychooncology. 7:1998;321-332.
3. Chalmers I., Dickersin K., Chalmers T.C. Getting to grips with Archie Cochrane's agenda. Br Med J. 305:1992;786-788.
4. Hansten PD, Horn JR, Koda-Kimble MA, Young LY (eds): Drug Interactions and Analysis and Management. Facts and Comparisons. St. Louis, MO, quarterly Update, 1999.
5. Tatro DS (ed): Drug Interaction Facts. St. Louis: Facts and Comparisons, 1998. Quarterly Update 1999.
6. Micromedex Drugdex, Micromedex, Vol 97, Englewood, NJ, 1998.
7. McEvoy GK (ed): American Hospital Formulary Service Drug Information 1999. American Society of Health System Pharmacists. Bethesda, MD.
8. Sewester CS, Olin B, Hebel SK, et al (eds): Drug Facts and Comparisons. St Louis: Facts and Comparisons, 1999. Monthly Update March 1999.
9. nd ed. New York, Elsevier, 1992.
10. Slaughter R.I., Edwards D.J. Recent advanced the cytochrome p450 enzymes . Ann Pharacother. 29:1995;619-624.
11. nd ed. Spokane, Applied Therapeutics, 1986.
12. th ed. Elmsford, New York, Pergamon Press, 1990.
13. nd ed. Baltimore, Williams & Wilkins, 1986.
14. Jankel C.A., Speedie S.M. Detecting drug interactions a review of the literature. DICP . Ann Pharmacother. 24:1990;282-289.
15. Poirier TI, Giudici R: Evaluation of drug interactions microcomputer software: an updated comparison. Hosp Pharm 30:888-890, 893-894, 1995.
16. Ryan J.L., Rinke R., deLeon R. Selecting a pharmacy computer system for the future. Pharm Pract Manage Q. 15:1995;1-14.
17. Dasta J.F. Enhancing the pharmacists computer interface. Ann Pharmacother. 26:1992;99-100.
18. Rosenberg J.M., Fuentes R.J., Starr C.H., et al. Directory of pharmacist-operated drug information centers in the United States. J Pharm Technol. 11:1995;1-5.
19. Colvin C.L. Drug information services provided by the pharmaceutical industry. Am J Hosp Pharmacol. 47:1990;1989-2001.
20. Rosenberg J.M., Fuentes R.J., Starr C.H., et al. Pharmacist-operated drug information centers in the United States. J Pharm Technol. 11:1995;1-5.
21. Lee P.M. Automation and the future practice of pharmacy changing the focus of pharmacy . Pharmcol Pract Manag Q. 15:1995;23-25.
22. Anon. Learning Guide. Englewood, NJ, Micromedex Inc. Medical Economics, 1995.
23. MedAson Information Overview. First Data Bank Inc. San Bruno, CA. 1997.
24. Kivisto K.T., Kroemer H.K., Eichelbaum M. The role of human cytochrome p450 enzymes in the metabolism of anticancer agents implications for drug interactions . Br J Clin Pharmacol. 40:1995;523-530.
25. Dear Doctor Letter. Important changes to the prescribing information for accutane (isotretinoin). Roche Laboratories, Nutley, NJ February 1998.
26. The Cochrane Collaboration. The Cochrane Database of Systematic Reviews. BMJ Publishing Group, London 1999.